CEO
Brian Murphy
Employees
11
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
nemus bioscience is a publicly traded, life-science biotech company, developing regulatory-approved, cannabinoid-based therapies, for a spectrum of diseases, especially those of unmet medical need.
Loading...
Open
3.28
Mkt cap
111M
Volume
122K
High
3.47
P/E Ratio
6.90
52-wk high
19.41
Low
3.21
Div yield
N/A
52-wk low
2.25
Portfolio Pulse from
December 10, 2024 | 1:45 pm
Portfolio Pulse from
November 08, 2024 | 4:00 am
Portfolio Pulse from
November 07, 2024 | 9:15 pm
Portfolio Pulse from Benzinga Newsdesk
September 30, 2024 | 1:51 pm
Portfolio Pulse from Benzinga Newsdesk
September 23, 2024 | 2:29 pm
Portfolio Pulse from Benzinga Newsdesk
September 23, 2024 | 11:05 am
Portfolio Pulse from Vandana Singh
September 20, 2024 | 7:18 pm
Portfolio Pulse from Benzinga Newsdesk
September 20, 2024 | 5:57 pm
Portfolio Pulse from Benzinga Newsdesk
September 20, 2024 | 4:43 pm
Portfolio Pulse from Benzinga Newsdesk
September 20, 2024 | 4:35 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.